Hubungan Ekspresi Imunohistokimia Vascular Endothelial Growth Factor (VEGF) dan Tumor-infiltrating lymphocytes (TILs) dengan Tipe Histopatologi dan Stadium Klinis Karsinoma Nasofaring
DAFTAR PUSTAKA
1. Chan JKC, Bray F, McCarron. Nasopharyngeal Carcinoma. In: Barnes L.
Eveson JW, Reichart P, Sidransky D. Pathology and Genetic Head and
Neck Tumours. 2005. IARC Press. Lyon. p.82-97.
2. Kurnianda J.et al. Elevation of Vascular Endothelial Growth Factor in
Indonesian Advanced Stage Nasopharyngeal Carcinoma. Kobe J. Med.
Sci. Vo.55, No.2. p.E36-44. Available from:http//www.med.kobeu.ac.jp/journal/content/55/E36.pdf.
3. Farhat. Vascular Endothelial Growth Factor pada Karsinoma Nasofaring.
Majalah Kedokteran Nusantara. Volume 42. No.1. Maret 2009. Available
from:http//www.repository.usu.ac.id/bitstream/123456789/18354/1/mknmar2009-42%20(4).pdf.
4. Rosai J. Nasal Cavity, Paranasal Sinuses, and Nasopharynx. In: Rosai and
Ackerman’s Surgical Pathology 10 th ed. Elsevier. Philadelphia; 2011.
5. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran-Pathologic
Basis of Disease 8th ed. Saunders. Philadelphia; 2010. p.785-7.
6. Sha D, He YJ. Expression and Clinical Significance of VEGF and Its
Receptors Flt-1 and KDR in Nasopharyngeal Carcinoma. Ai Zheng. 2006.
Available from:http//www.ncbi.nlm.nih.gov/pubmed/16480593.
7. Khrisna SM, James S, Balaram P. Expression of VEGF as Prognosticator
in Primary Nasopharyngeal Cancer and Its Relation to EBV Status. Virus
Res,
115.
2006.
Available
from:
http//www.sciencedirect.com/science/article/pii/S016870205002327
8. Soo R. et al. Overexpression of Cyclooxygenase-2 in Nasopharyngeal
Carcinoma and Association With Epidermal Growth Factor Receptor
Expression. Arch Otolaryngol Head and Neck Surg. Vol.131. 2005. p.14752. Available from: http//www.ncbi.nlm.nih.gov/pubmed/15723947.
9. Li HY et al. Elevated Expression of Survivin and VEGF Protein are
Strong Independent Predictors of Survival in Advanced Nasopharyngeal
Carcinoma. Journal of Translational Medicine. 2008. 6: 1. Doi:
10.1186/1479-5876-6-1.
10. Yu P, Fu YX. Tumor-infiltrating T Lymphocytes: Friends or Foes.
Laboratory
Investigation
(2006)
86,231-245.
DOI:10.1038/labinvest.3700389
11. Uppaluri R, Dunn GP, Lewis JS. Focus on TILs: Prognostic Significance
of Tumor Infiltrating Lymphocytes in Head and Neck Cancers. Cancer
Immunity.
Vol.8,
p.16.
Available
from:
http//www.ncbi.nlm.nih.gov/pmc/articles/PMC2935779
12. Salgado R. et al. The Evaluation of Tumor-Infiltrating Lymphocytes
(TILs) in Breast Cancer: Recommendations by an International TILs
Working Group 2014. Ann Oncol (2015) 26 (2): 259-71. DOI:
10.1093/1nnonc/mdu450.
Universitas Sumatera Utara
13. Mills SE. Larynx and Pharynx. In: Mills SE, ed. Histology for
Pathologists. 3rd. Lippincott Wiliiams & Wilkins; 2007.
14. Mills SE, Carter D, Greenson JK, Oberman HA, Reuter VE, Stoler MH.
The Nose, Paranasal Sinuses, and Nasopharynx. In: Stenberg’s Diagnostic
Surgical Pathology 4th ed. Lippincott Williams & Wilkins; 2004.
15. Ganguly NK, Satyanarayana K, Srivastava VK, et al. Epidemiological and
Etiological Factors Associated with Nasopharyngeal Carcinoma. ICMR
Bulletin
2003;
33(9).
Available
from:
http//www.icmr.nic.in/BUSEPT03.pdf
16. Hidayat B. Hubungan Antara Gambaran Timpanometri Dengan Letak dan
Stadium Tumor Pada Penderita Karsinoma Nasofaring di Departemen
THT-KL RSUP H. Adam Malik Medan. Fakultas Kedokteran Universitas
Sumatera
Utara;
2009.
Available
from:
http://www.repository.usu.ac.id/handle/123456789/6424
17. Adham M, Roezin A. Karsinoma Nasofaring. Dalam: Soepardi EA,
Iskandar N, Bashiruddin J, Restuti RD. Buku Ajar Ilmu Kesehatan
Telinga Hidung Tenggorok Kepala & Leher. Edisi ke-enam. Balai
Penerbit FK-UI. Jakarta; 2007. p.182-7.
18. Munir M. Keganasan di Bidang Telinga Hidung Tenggorok. Dalam:
Soepardi EA, Iskandar N, Bashiruddin J, Restuti RD. Buku Ajar Ilmu
Kesehatan Telinga Hidung Tenggorok Kepala & Leher. Edisi ke-enam.
Balai Penerbit FK-UI. Jakarta; 2007. p.162-73
19. Munir D. Peran Gen HLA-DRB1 dan HLA-DQB1 Sebagai Penyebab
Kerentanan Timbulnya Karsinoma Nasofaring pada Suku Batak. ORLI.
Vol.38
no.3,4.
p.15-23.
Available
from:
http://www.repository.usu.ac.id/bitstream/123456789/18625/1/mknsep2008-41%20%283%29.pdf
20. Tambunan, WG. Sepuluh Jenis Kanker Terbanyak di Indonesia. EGC.
Jakarta; 1991. p.67-87.
21. Piasiska H. Profil Penderita Karsinoma Nasofaring di Laboratorium
Patologi Anatomi kota Medan. Fakultas Kedokteran Universitas Sumatera
Utara;
2010.
Available
from:
http://www.repository.usu.ac.id/handle/123456789/16912
22. Barnes L. Disease of the Nasal Cavity, Paranasal Sinuses, and
Nasopharynx. In : Barnes L, ed. Surgical Pathology of The Head and
Neck. 3rd. New York: Informa Helathcare; 2009. p.360-401.
23. Wenig BM, Richardson M. Nasal Cavity, Paranasal Sinuses, and
Nasopharynx. In: Weidner, Cote, Suster, Weiss,ed. Modern Surgical
Pathology. 2nd ed.Philadelphia : Saunders Elsevier; 2009. p.14-192.
24. Probst R, Grevers G, Iro H. Basic Otorhinolaryngology a Step by Step
Learning Guide.2006. Thieme.New York. p.108-11.
25. American Cancer Society. Nasopharyngeal Cancer. [cited 2014 Aug 8].
Available
from:
http://www.cancer.org/acs/groups/cid/documents/webcontent/003124-pdf
Universitas Sumatera Utara
26. Dsouza C, Jabeen M, Pai P.K. Human Papilloma Virus Detection by
Immunohistochemistry on Sinonasal Papillomas and Nasopharyngeal
Carcinomas: Report on 26 Cases. DOI; 10.4103/2321-4848.113552.
27. Dabbs D. Diagnostic Immunohistochemistry. 2nd ed. Churcill Livingstone.
New York; 2006. p.270-1.
28. Lee AWM. Contribution of Radiotherapy to Function Preservation and
Cancer Outcome in Primary Treatment of Nasopharyngeal Carcinoma.
World Journal of Surgery 2003; 27: 838-40. Available from:
http://www.researchgate.net/publication/9079615
29. Mariotti M, Maier JAM. Angiogenesis: an Overview. In: Forough R. New
Frontiers in Angiogenesis. Springer. Netherlands; 2006. p.1-29.
30. Wever O and Mareel M. Role of Tissue Stroma in Cancer Cell Invasion.
Available from: http://onlinelibrary.wiley.com/doi/10.1002/path.1398/pdf.
31. Monoclonal Mouse Anti-Human Vascular Endothelial Growth Factor
Clone
VG1.
Available
from:http//www.dako.com/download.pdf?objectid=108411003
32. VEGF Antibody Staining Protocol for Immunohistochemistry. IHCWorld.
Available
from:http//www.ihcworld.com/_protocols/antibody_protocols/vegf_vg1_c
hemicon.htm
33. Geng Y. et al. Prognostic Role of Tumor-Infiltrating Lymphocytes in
Lung Cancer: a Meta-Analysis. Cell Physiol Biochem 2015;37:15601571. DOI: 10.1159/000438523
34. Gooden MJM et al. The Prognostic Influence of Tumor-Infiltrating
Lymphocytes in Cancer: a Systematic Review With Meta-Analysis.
British Journal on Cancer (2011) 105, 93-103. Available
from:http//www.ncbi.nlm.nih.gov/pmc/articles/PMC3137407/.
35. Harahap MPH. Ekspresi Vascular Endothelial Growth Factor pada
Karsinoma Nasofaring. Fakultas Kedokteran Universitas Sumatera Utara;
2009.
Available
from:
http://www.repository.usu.ac.id/handle/123456789/6425
Universitas Sumatera Utara
1. Chan JKC, Bray F, McCarron. Nasopharyngeal Carcinoma. In: Barnes L.
Eveson JW, Reichart P, Sidransky D. Pathology and Genetic Head and
Neck Tumours. 2005. IARC Press. Lyon. p.82-97.
2. Kurnianda J.et al. Elevation of Vascular Endothelial Growth Factor in
Indonesian Advanced Stage Nasopharyngeal Carcinoma. Kobe J. Med.
Sci. Vo.55, No.2. p.E36-44. Available from:http//www.med.kobeu.ac.jp/journal/content/55/E36.pdf.
3. Farhat. Vascular Endothelial Growth Factor pada Karsinoma Nasofaring.
Majalah Kedokteran Nusantara. Volume 42. No.1. Maret 2009. Available
from:http//www.repository.usu.ac.id/bitstream/123456789/18354/1/mknmar2009-42%20(4).pdf.
4. Rosai J. Nasal Cavity, Paranasal Sinuses, and Nasopharynx. In: Rosai and
Ackerman’s Surgical Pathology 10 th ed. Elsevier. Philadelphia; 2011.
5. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran-Pathologic
Basis of Disease 8th ed. Saunders. Philadelphia; 2010. p.785-7.
6. Sha D, He YJ. Expression and Clinical Significance of VEGF and Its
Receptors Flt-1 and KDR in Nasopharyngeal Carcinoma. Ai Zheng. 2006.
Available from:http//www.ncbi.nlm.nih.gov/pubmed/16480593.
7. Khrisna SM, James S, Balaram P. Expression of VEGF as Prognosticator
in Primary Nasopharyngeal Cancer and Its Relation to EBV Status. Virus
Res,
115.
2006.
Available
from:
http//www.sciencedirect.com/science/article/pii/S016870205002327
8. Soo R. et al. Overexpression of Cyclooxygenase-2 in Nasopharyngeal
Carcinoma and Association With Epidermal Growth Factor Receptor
Expression. Arch Otolaryngol Head and Neck Surg. Vol.131. 2005. p.14752. Available from: http//www.ncbi.nlm.nih.gov/pubmed/15723947.
9. Li HY et al. Elevated Expression of Survivin and VEGF Protein are
Strong Independent Predictors of Survival in Advanced Nasopharyngeal
Carcinoma. Journal of Translational Medicine. 2008. 6: 1. Doi:
10.1186/1479-5876-6-1.
10. Yu P, Fu YX. Tumor-infiltrating T Lymphocytes: Friends or Foes.
Laboratory
Investigation
(2006)
86,231-245.
DOI:10.1038/labinvest.3700389
11. Uppaluri R, Dunn GP, Lewis JS. Focus on TILs: Prognostic Significance
of Tumor Infiltrating Lymphocytes in Head and Neck Cancers. Cancer
Immunity.
Vol.8,
p.16.
Available
from:
http//www.ncbi.nlm.nih.gov/pmc/articles/PMC2935779
12. Salgado R. et al. The Evaluation of Tumor-Infiltrating Lymphocytes
(TILs) in Breast Cancer: Recommendations by an International TILs
Working Group 2014. Ann Oncol (2015) 26 (2): 259-71. DOI:
10.1093/1nnonc/mdu450.
Universitas Sumatera Utara
13. Mills SE. Larynx and Pharynx. In: Mills SE, ed. Histology for
Pathologists. 3rd. Lippincott Wiliiams & Wilkins; 2007.
14. Mills SE, Carter D, Greenson JK, Oberman HA, Reuter VE, Stoler MH.
The Nose, Paranasal Sinuses, and Nasopharynx. In: Stenberg’s Diagnostic
Surgical Pathology 4th ed. Lippincott Williams & Wilkins; 2004.
15. Ganguly NK, Satyanarayana K, Srivastava VK, et al. Epidemiological and
Etiological Factors Associated with Nasopharyngeal Carcinoma. ICMR
Bulletin
2003;
33(9).
Available
from:
http//www.icmr.nic.in/BUSEPT03.pdf
16. Hidayat B. Hubungan Antara Gambaran Timpanometri Dengan Letak dan
Stadium Tumor Pada Penderita Karsinoma Nasofaring di Departemen
THT-KL RSUP H. Adam Malik Medan. Fakultas Kedokteran Universitas
Sumatera
Utara;
2009.
Available
from:
http://www.repository.usu.ac.id/handle/123456789/6424
17. Adham M, Roezin A. Karsinoma Nasofaring. Dalam: Soepardi EA,
Iskandar N, Bashiruddin J, Restuti RD. Buku Ajar Ilmu Kesehatan
Telinga Hidung Tenggorok Kepala & Leher. Edisi ke-enam. Balai
Penerbit FK-UI. Jakarta; 2007. p.182-7.
18. Munir M. Keganasan di Bidang Telinga Hidung Tenggorok. Dalam:
Soepardi EA, Iskandar N, Bashiruddin J, Restuti RD. Buku Ajar Ilmu
Kesehatan Telinga Hidung Tenggorok Kepala & Leher. Edisi ke-enam.
Balai Penerbit FK-UI. Jakarta; 2007. p.162-73
19. Munir D. Peran Gen HLA-DRB1 dan HLA-DQB1 Sebagai Penyebab
Kerentanan Timbulnya Karsinoma Nasofaring pada Suku Batak. ORLI.
Vol.38
no.3,4.
p.15-23.
Available
from:
http://www.repository.usu.ac.id/bitstream/123456789/18625/1/mknsep2008-41%20%283%29.pdf
20. Tambunan, WG. Sepuluh Jenis Kanker Terbanyak di Indonesia. EGC.
Jakarta; 1991. p.67-87.
21. Piasiska H. Profil Penderita Karsinoma Nasofaring di Laboratorium
Patologi Anatomi kota Medan. Fakultas Kedokteran Universitas Sumatera
Utara;
2010.
Available
from:
http://www.repository.usu.ac.id/handle/123456789/16912
22. Barnes L. Disease of the Nasal Cavity, Paranasal Sinuses, and
Nasopharynx. In : Barnes L, ed. Surgical Pathology of The Head and
Neck. 3rd. New York: Informa Helathcare; 2009. p.360-401.
23. Wenig BM, Richardson M. Nasal Cavity, Paranasal Sinuses, and
Nasopharynx. In: Weidner, Cote, Suster, Weiss,ed. Modern Surgical
Pathology. 2nd ed.Philadelphia : Saunders Elsevier; 2009. p.14-192.
24. Probst R, Grevers G, Iro H. Basic Otorhinolaryngology a Step by Step
Learning Guide.2006. Thieme.New York. p.108-11.
25. American Cancer Society. Nasopharyngeal Cancer. [cited 2014 Aug 8].
Available
from:
http://www.cancer.org/acs/groups/cid/documents/webcontent/003124-pdf
Universitas Sumatera Utara
26. Dsouza C, Jabeen M, Pai P.K. Human Papilloma Virus Detection by
Immunohistochemistry on Sinonasal Papillomas and Nasopharyngeal
Carcinomas: Report on 26 Cases. DOI; 10.4103/2321-4848.113552.
27. Dabbs D. Diagnostic Immunohistochemistry. 2nd ed. Churcill Livingstone.
New York; 2006. p.270-1.
28. Lee AWM. Contribution of Radiotherapy to Function Preservation and
Cancer Outcome in Primary Treatment of Nasopharyngeal Carcinoma.
World Journal of Surgery 2003; 27: 838-40. Available from:
http://www.researchgate.net/publication/9079615
29. Mariotti M, Maier JAM. Angiogenesis: an Overview. In: Forough R. New
Frontiers in Angiogenesis. Springer. Netherlands; 2006. p.1-29.
30. Wever O and Mareel M. Role of Tissue Stroma in Cancer Cell Invasion.
Available from: http://onlinelibrary.wiley.com/doi/10.1002/path.1398/pdf.
31. Monoclonal Mouse Anti-Human Vascular Endothelial Growth Factor
Clone
VG1.
Available
from:http//www.dako.com/download.pdf?objectid=108411003
32. VEGF Antibody Staining Protocol for Immunohistochemistry. IHCWorld.
Available
from:http//www.ihcworld.com/_protocols/antibody_protocols/vegf_vg1_c
hemicon.htm
33. Geng Y. et al. Prognostic Role of Tumor-Infiltrating Lymphocytes in
Lung Cancer: a Meta-Analysis. Cell Physiol Biochem 2015;37:15601571. DOI: 10.1159/000438523
34. Gooden MJM et al. The Prognostic Influence of Tumor-Infiltrating
Lymphocytes in Cancer: a Systematic Review With Meta-Analysis.
British Journal on Cancer (2011) 105, 93-103. Available
from:http//www.ncbi.nlm.nih.gov/pmc/articles/PMC3137407/.
35. Harahap MPH. Ekspresi Vascular Endothelial Growth Factor pada
Karsinoma Nasofaring. Fakultas Kedokteran Universitas Sumatera Utara;
2009.
Available
from:
http://www.repository.usu.ac.id/handle/123456789/6425
Universitas Sumatera Utara